Содержание
- 2. What is pharmacology? It is science of the drugs pharma ology Drug Science
- 3. What is Drug? It is the chemical that affect physiological body function through interaction with receptors
- 4. It is the chemical that affect physiological body function through interaction with receptors What is Drug?
- 5. A Response
- 6. Forces involved in D-R interaction Covalent bonds Ionic bonds Hydrogen bonds Vander waals bonds
- 7. Forces involved in D-R interaction Covalent bonds Ionic bonds Hydrogen bonds Vander waals bonds
- 8. Forces involved in D-R interaction Covalent bonds Strong irreversible Alkylating agents
- 9. Forces involved in D-R interaction Covalent bonds Ionic bonds Hydrogen bonds Vander waals bonds
- 10. Forces involved in D-R interaction Ionic bonds common Affected by pH
- 11. Forces involved in D-R interaction Covalent bonds Ionic bonds Hydrogen bonds Vander waals bonds
- 12. Forces involved in D-R interaction Hydrogen bonds ?
- 13. Forces involved in D-R interaction Covalent bonds Ionic bonds Hydrogen bonds Vander waals bonds
- 14. Forces involved in D-R interaction Vander waals bonds ?
- 15. Receptors types On cell membrane Intracellular Receptor with intrinsic ion channel GPCR Enzyme linked receptors
- 16. Receptors types On cell membrane Intracellular Transcription factors
- 18. Drug-Receptor Interaction D + R DR k1 K1 is association rate constant
- 19. Drug-Receptor Interaction D + R DR k2 K2 is dissociation rate constant
- 20. Drug-Receptor Interaction D + R DR k1 k2 At equilibrium
- 21. Drug-Receptor Interaction [D] [R] [DR] k1 k2 = At equilibrium
- 22. Drug-Receptor Interaction [D] [R] [DR] k1 k2 = At equilibrium
- 23. Drug-Receptor Interaction k2 k1 = [R] [D] [DR] kd Kd (dissociation equilibrium constant) is conc. of
- 24. kd It is a measure of drug affinity Its units is conc. units Drug A Drug
- 25. Important concepts Affinity Efficacy potency
- 26. Affinity The ability of the drug to bind to the receptor Measured by Kd Both agonist
- 27. Efficacy It is the ability of the drugs to elicit pharmacological effect Measured by Emax Agonist
- 28. potency The ability of the drug to produce response at lower conc. Measured by ED50
- 29. The drug may be Agonist Antagonist Partial agonist
- 30. Agonist Has affinity and efficacy IA=1
- 31. Antagonist Has affinity but no efficacy IA=0
- 32. Partial agonist Has affinity and efficacy IA=0-1
- 33. antagonism Physical Chemical Physiological Pharmacokinetic pharmacodynamic
- 34. Chemical antagonism One drug reacts chemically with an active drug to form an inactive compound, It
- 35. Physiological antagonism 2 drugs act on different sites in the same or different system. a- Intended
- 36. Pharmacokinetic antagonism (ADME) a- Intended ? forced alkaline diuresis in management of barb Poisoning. b- Incidental
- 37. Pharmacodynamic antagonist Competitive Non-competitive Reversible Surmountable antagonism Ach. + atropine
- 38. Pharmacodynamic antagonist Competitive Non-competitive Irreversible Reversible Non-surmountable antagonism Ach. + succinylcholine
- 39. An A X
- 40. A X An
- 41. Dose-Response Curve What ? Types ?
- 42. Dose Response Hyperbolic curve
- 43. Log dose Response Sigmoidal shaped curve
- 44. Log dose Response Linear
- 45. Log dose Response Wide range of doses
- 46. Log dose Response ED50 can be calculated ED50
- 47. Graded DRC Depends on graded response ED50 ? The dose that give 50% of maximal response
- 48. Log dose Response ED50 50%
- 49. Quantal DRC Depends on quantal response ED50 ? The dose that give response in 50% of
- 50. Log dose %Response ED50 50%
- 51. ED50 Compare between potencies of two drugs Drug A Drug B Has higher ED50 than Which
- 52. ED50 Calculation of the therapeutic index TI LD50 = Is a measure of drug safety ED50
- 53. Log dose Response ED50 50% LD50 TI
- 54. Log dose Response ED50 50% LD50 TI
- 55. Drug A Drug B Has higher TI than Which one is more safer ?
- 56. DRC & antagonists Competitive reversible antagonist Log dose Response
- 57. DRC & antagonists Competitive irreversible antagonist Log dose Response
- 58. DRC & antagonists non-competitive antagonist Log dose Response
- 59. Important notes Parrallism Indicate competition
- 60. Important notes Emax Indicate reversibility
- 62. Скачать презентацию